The price concession can carry a financing business inside it

## Bring the cash condition into the opening comparison

A discount arrives in a form people can recognise quickly. Two per cent sounds precise, commercial and easy to compare. The condition attached to it may receive less attention: an advance, a maintained balance or an earlier payment date. Those terms can change the economics more than the price percentage itself. I want the cash condition in the opening comparison, because a proposal that requires the company to fund another party is doing more than buying a service at a lower price. It is also allocating money for a period and accepting the consequences of that allocation.

The fictional hospital-network proposal we examined offered 2% on ₹20 crore of eligible annual bills. On that assumption, the concession was ₹40 lakh. It required an ₹8 crore advance maintained for twelve months. At the model's 8% annual funding assumption, that balance carried ₹64 lakh of cost. The simple difference was ₹24 lakh against the proposal before other considerations. We did not need a complicated model to see that the initial slide, which emphasised the discount, had left out a consequential part of the transaction. We did need to explain exactly what each number assumed so colleagues could assess whether those assumptions were reasonable.

The provider-management team had a legitimate commercial argument. The relationship mattered, a concession was available and the quoted percentage could improve the visible cost of eligible services. I did not want the financial review to dismiss that work. I wanted it to examine the whole exchange being proposed. An advance can sometimes be justified by better access, lower total cost or another lawful and properly assessed commercial benefit. The problem is not its existence. The problem is treating it as though the company has supplied no valuable resource simply because the corresponding amount does not appear in the service-price column.

The distinction also protects professional boundaries in health insurance. A discussion of provider payment terms should not become a reason to alter a policyholder's benefits or substitute a financial preference for a clinical or coverage decision. Those responsibilities remain with the appropriate owners and processes. My contribution was to make the commercial funding account clear for authorised decision-makers. Legal colleagues examined the agreement, and provider-management colleagues assessed the relationship. The finance model was one part of that review. It did not establish the quality of treatment, the validity of a claim or the suitability of the provider for every service.

## Keep the model's assumptions visible

The 8% rate was a planning assumption, not interest already paid on a loan taken for the proposal. That matters because a model can accidentally turn a comparison into an apparent historical fact. Similarly, ₹20 crore represented the eligible annual bill volume used in the offer. A different eligible base would change the projected discount. The ₹8 crore advance was assumed to remain outstanding for the full year. If its balance or duration changed, the funding calculation would change too. These are not minor qualifications to an otherwise final answer. They are the terms that give the answer its meaning.

I prefer to show those assumptions in ordinary language beside the arithmetic. Colleagues can then ask useful questions: would the advance actually remain constant, which bills qualify, how is the concession settled, and what happens if the relationship changes? Counterparty exposure and contractual protection also matter. A favourable net percentage would not remove the need to assess the possibility that an advance becomes difficult to recover or cannot be applied as expected. The review should identify those questions without inventing a probability merely to complete a spreadsheet. Some matters need legal or commercial resolution before a financial conclusion can be treated as actionable.

There is also a difference between a company's funding cost and the availability of cash on a particular day. A comfortable bank balance does not make a year-long allocation free. The money may have other planned uses, and the business may need to preserve access for obligations that are not optional. Conversely, a standard funding rate should not be applied mechanically if it poorly represents the decision being made. Finance should explain why the chosen assumption is relevant and how a reasonable alternative would affect the recommendation. The purpose is a transparent comparison, not a number selected to secure a preferred outcome.

Our review cost ₹19 lakh in financial and contractual work. That expense belonged to the actual account even though we ultimately declined the proposal. It would be misleading to present the decision as costless simply because the larger advance was not made. The review helped the CEO choose ordinary settlement terms on the facts presented. It also gave the commercial team a clearer basis for future negotiation. They could discuss a different balance, period or eligible volume with an understanding of what would need to change. A rejected proposal can therefore produce useful learning without being relabelled as a completed saving programme.

## Declining the proposal does not create the projected saving

We did not enter the year-long advance arrangement, so the projected ₹64 lakh funding charge was never incurred under that proposal. Neither was the projected ₹40 lakh concession earned. The ₹24 lakh comparison explained the recommendation; it did not become realised profit when the CEO accepted it. This distinction is particularly important in finance narratives, where an avoided forecast can easily become a claimed benefit. The company made a different commercial choice and incurred the review expense. Its actual performance under ordinary settlement terms remained part of the ongoing operating account, with all the other factors that affected it.

I also would not turn the case into a general instruction to refuse provider advances. Different circumstances could support a different outcome. A smaller maintained balance, a shorter period or a different volume could alter the economics, while legal, operational and counterparty considerations would still require assessment. The value of the example lies in the method: place the cash condition and the price concession in the same comparison, identify the assumptions and preserve the authority of the people responsible for the other parts of the decision. It is an account of executive judgement within a fictional business, not a financial prescription for another organisation.

A board can make this discipline part of its expectations without reviewing every payment term. Directors can ask whether material commercial proposals include the working-capital commitment, whether the assumptions have named owners and whether the reported benefit is forecast or realised. They can also ask what the company gives up by declining. That last question keeps the review honest. A proposal can be unattractive on the model presented and still contain a relationship opportunity worth pursuing differently. Finance should make that possibility visible rather than use a negative comparison to close a conversation that could produce a better arrangement.

I want commercial colleagues to bring the whole proposal early, including the condition that seems awkward to explain. The discount, advance, duration and protections belong together because they are parts of one exchange. In our case, putting them together led to a decision to retain ordinary terms. The relationship continued, and the company did not claim a saving it had never earned. That is a useful result: a clearer commitment, a documented cost of reaching it and a better understanding of what a future negotiation would have to change. The attractive percentage could then return to its proper role as one term in the decision.